The role of receptor structure in determining adenosine receptor activity

Pharmacology and Therapeutics

Volumn 85, Issue 2, 2000, Pages 55-75

  Olah, Mark E ^a   Stiles, Gary L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenosine; Adenosine receptors; Desensitization; G proteins; Mutagenesis; Signal transduction

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR; PHENYLISOPROPYLADENOSINE; RECEPTOR SUBTYPE;

AMINO ACID SEQUENCE; DESENSITIZATION; GENE EXPRESSION REGULATION; HUMAN; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

BINDING, COMPETITIVE; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; HUMANS; LIGANDS; RECEPTORS, PURINERGIC P1; SIGNAL TRANSDUCTION;

EID: 0033971607     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(99)00051-0     Document Type: Review

References (132)

1. Ali H., Cunha-Melo J.R., Saul W.F., Beaven M.A. Activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen-stimulated RBL-2H3 cells. J Biol Chem. 265:1990;745-753.
2. 2B receptor Mol Pharmacol. 52:1997;846-860. a.
3. 6-(3-iodobenzyl)adenosine-5′-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res. 80:1997;800-809. b.
4. 1 adenosine receptor. influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding Mol Pharmacol. 50:1996;1635-1642.
5. 2-adenosine receptor binding subunit. Mol Pharmacol. 38:1990;177-183.
6. 1 adenosine receptors. Mol Pharmacol. 50:1996;104-111.
7. q/11 by the m3 muscarinic acetylcholine receptor. J Biol Chem. 270:1995;17741-17748.
8. 1 receptor binding and function by 2-amino-3-benzoylthiophenes. Mol Pharmacol. 38:1990;939-949.
9. 3H]NECA in rat striatal membranes. Mol Pharmacol. 29:1986;331-346.
10. Chern Y., Chiou J.-Y., Lai H.-L., Tsai M.-H. Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response. role for protein phosphatase 2A Mol Pharmacol. 48:1995;1-8.
11. Chu Y.-Y., Tu K.-H., Lee Y.C., Kuo Z.-J., Lai H.-L., Chern Y. Characterization of the rat A2a adenosine receptor gene. DNA Cell Biol. 15:1996;329-337.
12. 1 adenosine receptors. Mol Pharmacol. 52:1997;788-797.
13. Colquhoun D. Binding, gating, affinity and efficacy. the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors Br J Pharmacol. 125:1998;924-947.
14. Cotecchia S., Ostrowski J., Kjelsberg M.A., Caron M.G., Lefkowitz R.J. Discrete amino acid sequences of the α1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. J Biol Chem. 267:1992;1633-1639.
15. Daaka Y., Luttrell L.M., Ahn S., Della Rocca G.J., Ferguson S.S.G., Caron M.G., Lefkowitz R.J. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J Biol Chem. 273:1998;685-688.
16. 2A-adrenergic receptor alter receptor G protein coupling by distinct mechanisms. J Biol Chem. 266:1991;11025-11029.
17. Daly J.W., Butts-Lamb P., Padgett W. Subclasses of adenosine receptors in the central nervous system. interaction with caffeine and related methylxanthines Cell Mol Neurobiol. 3:1983;69-80.
18. 2 receptors in stably cotransfected fibroblast cells. Eur J Pharmacol. 316:1996;325-331.
19. 2 receptors? Pharmacol Ther. 71:1996;325-335.
20. Downey J.M., Cohen M.V., Ytrehus K., Liu Y. Cellular mechanisms in ischemic preconditioning. the role of adenosine and protein kinase Cα Ann N Y Acad Sci. 723:1994;82-98.
21. 2A-adrenergic receptor. J Biol Chem. 270:1995;24753-24760.
22. 1 MF-2 cells. comparison of receptor density and response Eur J Pharmacol. 289:1995;305-310.
23. 2b receptors evoke interleukin-8 secretion in human mast cells. J Clin Invest. 96:1995;1979-1986.
24. 2B receptors. Pharmacol Rev. 49:1997;381-402.
25. 2B receptors. a novel therapeutic target in asthma? Trends Pharmacol Sci. 19:1998;148-153.
26. Ferré S., Von Euler B., Johansson B., Fredholm B.B., Fuxe K. Stimulation of high affinity adenosine A-2 receptors decreases the affinity of dopamine D-2 receptors in the neostriatum. Proc Natl Acad Sci USA. 88:1991;7237-7241.
27. Ferré S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20:1997;482-487.
28. 2 dopamine receptors in rat striatum Mol Brain Res. 14:1992;186-195.
29. Fong T.M., Strader C.D. Functional mapping of the ligand binding sites of G-protein coupled receptors. Med Res Rev. 14:1994;387-399.
30. Fredholm B.B. Adenosine and neuroprotection. Int Rev Neurobiol. 40:1997;259-280.
31. 2 receptor. Mol Brain Res. 15:1992;62-66.
32. Gether U., Kobilka B.K. G protein-coupled receptors. II. Mechanism of agonist activation. J Biol Chem. 273:1998;17979-17982.
33. i-coupled signal transduction. J Biol Chem. 273:1998;14912-14919.
34. 2 dopamine receptor isoforms. Nature. 342:1989;923-926.
35. 1 adenosine receptor agonist. J Biol Chem. 262:1987;13483-13490.
36. 1 adenosine receptor agonist. J Biol Chem. 265:1990;5206-5210.
37. 2a receptor involves activation of both N- and P-type calcium channels by different G proteins and protein kinases in the same striatal nerve terminals. J Neurochem. 67:1996;374-381.
38. + exchange. Nature. 392:1998;626-630.
39. 1AR mRNA expression or G protein α-subunit content. J Neurochem. 71:1998;221-230.
40. 1 adenosine receptor-adenylyl cyclase system in cerebellar granule cells. J Neurochem. 67:1996;1921-1930.
41. 2-adrenergic receptors by sodium. J Biol Chem. 265:1990;21590-21595.
42. 3 receptors. novel ligands and paradoxical effects Trends Pharmacol Sci. 19:1998;183-191.
43. Jacobson K.A., von Lubitz D.K.J.E., Daly J.W., Fredholm B.B. Adenosine receptor ligands. differences with acute versus chronic treatment Trends Pharmacol Sci. 17:1996;108-113.
44. 2b adenosine receptor gene (ADORA2B) and its pseudogene. Genomics. 27:1995;374-376.
45. Ji T.H., Grossmann M., Ji I. G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J Biol Chem. 273:1998;17299-17302.
46. 2A adenosine receptors are required for ligand recognition. Mol Pharmacol. 50:1996;512-521.
47. 1-adenosine receptor. J Biol Chem. 269:1994;32077-32084.
48. Kai H., Griendling K.K., Lassègue B., Ollerenshaw J.D., Runge M.S., Alexander R.W. Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor. Hypertension. 24:1994;523-527.
49. 2a adenosine receptor. J Biol Chem. 270:1995;13987-13997.
50. 2a adenosine receptor are required for ligand recognition. Mol Pharmacol. 49:1996;683-691.
51. 1 adenosine receptors in rat brain membranes. evidence for histidine in different domains of the ligand binding site J Biol Chem. 263:1988;17522-17526.
52. Kollias-Baker C., Ruble J., Dennis D., Bruns R.F., Linden J., Belardinelli L. Allosteric enhancer PD 81,723 acts by novel mechanism to potentiate cardiac actions of adenosine. Circ Res. 75:1994;961-971.
53. Krupnick J.G., Benovic J.L. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol. 38:1998;289-319.
54. Lai H.-L., Yang T.-H., Messing R.O., Ching Y.-H., Lin S.-C., Chern Y. Protein kinase C inhibits adenylyl cyclase type VI activity during desensitization of the A2a-adenosine receptor-mediated cAMP response. J Biol Chem. 272:1997;4970-4977.
55. 2 adenosine receptors. their presence and neuromodulatory role in the central nervous system Gen Pharmacol. 27:1996;925-933.
56. Lechleiter J., Hellmiss R., Duerson K., Ennulat D., David N., Clapham D., Peralta E. Distinct sequence elements control the specificity of G protein activation by muscarinic acetylcholine receptor subtypes. EMBO J. 9:1990;4381-4390.
57. Lefkowitz R.J. G protein-coupled receptors. III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J Biol Chem. 273:1998;18677-18680.
58. 1 adenosine receptor-mediated inhibition of cardiac myocyte contractility and adenylate cyclase activity. Circ Res. 67:1990;406-413.
59. Libert F., Parmentier M., Lefort A., Dinsart C., Van Sande J., Maenhaut C., Simons M.-J., Dumont J.E., Vassart G. Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science. 244:1989;569-572.
60. Libert F., Schiffman S.N., Lefort A., Parmentier M., Gerard C., Dumont J.E., Vanderhaegen J.-J., Vassart G. The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. EMBO J. 10:1991;1677-1682.
61. Libert F., Van Sande J., Lefort A., Czernilofsky A., Dumont J.E., Vassart G., Ensinger H.A., Mendla K.D. Cloning and functional characterization of a human A1 adenosine receptor. Biochem Biophys Res Commun. 187:1992;919-926.
62. s. J Biol Chem. 266:1991;4816-4821.
63. 3 adenosine receptor with widespread tissue distribution. Mol Pharmacol. 44:1993;524-532.
64. Liu J., Conklin B.R., Blin N., Yun J., Wess J. Identification of a receptor/G-protein contact site critical for signaling specificity and G-protein activation. Proc Natl Acad Sci USA. 92:1995;11642-11646.
65. Londos C., Cooper D.M.F., Wolff J. Subclasses of external adenosine receptors. Proc Natl Acad Sci USA. 77:1980;2551-2554.
66. iα are not associated with changes in their mRNAs Mol Pharmacol. 36:1989;681-688.
67. 2-adrenoceptor. Mol Pharmacol. 48:1995;316-325.
68. Maenhaut C., Van Sande J., Libert F., Abramowicz M., Parmentier M., Vanderhaegen J.-J., Dumont J.E., Vassart G., Schiffmann S. RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem Biophys Res Commun. 173:1990;1169-1178.
69. 1 adenosine receptor from rat brain. Mol Pharmacol. 40:1991;1-7.
70. 2 receptor are involved in functional G protein-mediated coupling to adenylyl cyclase. FEBS Lett. 325:1993;215-219.
71. Marquardt D.L., Walker L.L., Heinemann S. Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. J Immunol. 152:1994;4508-4515.
72. Meyerhof W., Muller-Brechlin R., Richter D. Molecular cloning of a novel putative G-protein coupled receptor expressed during rat spermiogenesis. FEBS Lett. 284:1991;155-160.
73. 1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs. Circ Res. 79:1996;415-423.
74. 2 dopamine receptors produced by alternative RNA splicing. Nature. 342:1989;926-929.
75. Moro O., Lameh J., Högger P., Sadée W. Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. J Biol Chem. 268:1993;22273-22276.
76. Mubagwa K., Mullane K., Flameng W. Role of adenosine in the heart and circulation. Cardiovasc Res. 32:1996;797-813.
77. 1 receptor. Am J Physiol. 264:1993;H1017-H1022.
78. 2 receptor desensitization. Mol Pharmacol. 51:1997;991-998.
79. Murrison E.M., Goodson S.J., Edbrooke M.R., Harris C.A. Cloning and characterisation of the human adenosine A3 receptor gene. FEBS Lett. 384:1996;243-246.
80. Namba T., Sugimoto Y., Negishi M., Irie A., Ushikubi F., Kakizuka A., Ito S., Ichikawa A., Narumiya S. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature. 365:1993;307-308.
81. Neve K.A., Cox B.A., Henningsen R.A., Spanoyannis A., Neve R.L. Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol Pharmacol. 39:1991;733-739.
82. 1 MF-2 cells. Mol Pharmacol. 52:1997;456-464.
83. 2-adrenergic receptors based upon characteristics in primary structure. J Biol Chem. 267:1992;8342-8346.
84. s. J Biol Chem. 272:1997;337-344.
85. Olah M.E., Stiles G.L. Adenosine receptor subtypes. characterization and therapeutic regulation Annu Rev Pharmacol Toxicol. 35:1995;581-606.
86. Olah M.E., Stiles G.L. Site-directed mutagenesis and chimeric receptors in the study of receptor-ligand binding. Challiss R.A.J. Methods in Molecular Biology, Vol. 83, Receptor Signal Transduction Protocols. 1997;25-43 Humana Press, Totowa.
87. Olah M.E., Stiles G.L. Adenosine receptor-mediated signal transduction. Pelleg A., Belardinelli L. Effects of Extracellular Adenosine and ATP on Cardiac Myocytes. 1998;7-38 R. G. Landes Company, Austin.
88. 1 adenosine receptor. Arch Biochem Biophys. 283:1990;440-446.
89. 1 adenosine receptor. studies on the ligand binding site by site-directed mutagenesis J Biol Chem. 267:1992;10764-10770.
90. Olah M.E., Jacobson K.A., Stiles G.L. Identification of an adenosine receptor domain specifically involved in binding of 5′-substituted adenosine agonists. J Biol Chem. 269:1994;18016-18020. a.
91. 3 adenosine receptors J Biol Chem. 269:1994;24692-24698. b.
92. 2-adrenergic receptor. how structure elucidates function Annu Rev Pharmacol Toxicol. 32:1992;167-183.
93. 2a adenosine receptor domain specifically responsible for mediating short-term desensitization. Biochemistry. 36:1997;832-838.
94. 2 adenosine receptors by two antipeptide antibody preparations. Mol Pharmacol. 42:1992;391-397.
95. 2a adenosine receptor. delineation of multiple processes Mol Pharmacol. 45:1994;1082-1094.
96. 3 adenosine receptor. evidence for a G-protein-coupled receptor kinase-mediated mechanism J Biol Chem. 270:1995;29607-29613.
97. Palmer T.M., Benovic J.L., Stiles G.L. Molecular basis for subtype-specific desensitization of inhibitory adenosine receptors. J Biol Chem. 271:1996;15272-15278.
98. Peterfreund R.A., Gies E.K., Fink J.S. Protein kinase C regulates adenosine A2a receptor mRNA expression in SH-SY5Y cells. Eur J Pharmacol. 336:1997;71-80.
99. 2B adenosine receptors. Biochem Pharmacol. 55:1998;873-882.
100. Pierce K.D., Fulong T.J., Selbie L.A., Shine J. Molecular cloning and expression of an adenosine A2b receptor from human brain. Biochem Biophys Res Commun. 187:1992;86-93.
101. Pitcher J.A., Freedman N.J., Lefkowitz R.J. G protein-coupled receptor kinases. Annu Rev Biochem. 67:1998;653-692.
102. 1 MF-2 cells. Mol Pharmacol. 40:1991;639-647.
103. 1 adenosine receptor gene. evidence for alternative splicing J Biol Chem. 269:1994;3104-3110. a.
104. 1 adenosine receptor expression. Proc Natl Acad Sci USA. 91:1994;4864-4866. b.
105. 1 adenosine receptor gene direct the synthesis of distinct messenger RNAs that regulate receptor abundance. Mol Pharmacol. 48:1995;975-980.
106. 1 adenosine receptor gene promoter. Mol Pharmacol. 53:1998;43-51.
107. 1-adenosine receptor that is widely expressed in brain and spinal cord. Mol Endocrinol. 5:1991;1037-1048.
108. 2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol Sci. 18:1997;338-344.
109. Rivkees S.A., Reppert S.M. RFL9 encodes an A2b-adenosine receptor. Mol Endocrinol. 6:1992;1598-1604.
110. 2a adenosine receptors. J Biol Chem. 270:1995;20485-20490.
111. Sajjadi F.G., Boyle D.L., Domingo R.C., Firestein G.S. cDNA cloning and characterization of A3i, an alternatively spliced rat A3 adenosine receptor variant. FEBS Lett. 382:1996;125-129.
112. 3 adenosine receptor. Proc Natl Acad Sci USA. 90:1993;10365-10369.
113. 2A-adenosine receptor in primary human endothelial cells. J Biol Chem. 272:1997;5792-5799.
114. Stehle J.H., Rivkees S.A., Lee J.J., Weaver D.R., Deeds J.D., Reppert S.M. Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol Endocrinol. 6:1992;384-393.
115. 1 adenosine receptor-G protein coupling in bovine brain membranes. effects of guanine nucleotides, salt, and solubilization J Neurochem. 51:1988;1592-1598.
116. 1 adenosine receptor mediates specific agonist binding. J Biol Chem. 269:1994;2373-2376.
117. 1 adenosine receptor cDNA. Mol Brain Res. 16:1992;365-370.
118. Tucker A.L., Linden J. Cloned receptors and cardiovascular responses to adenosine. Cardiovasc Res. 27:1993;62-67.
119. 1 receptor cDNA. FEBS Lett. 297:1992;107-111.
120. 1 adenosine receptors. two amino acids are responsible for species differences in ligand recognition J Biol Chem. 269:1994;27900-27906.
121. 2-adrenergic receptor. EMBO J. 14:1995;5542-5549.
122. Van Calker D., Muller M., Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem. 33:1979;999-1005.
123. 3 adenosine receptor. Mol Pharmacol. 45:1994;1101-1111.
124. 1A receptors to adenylyl cyclase Mol Pharmacol. 41:1992;999-1007.
125. Vogel W.K., Mosser V.A., Bulseco D.A., Schimerlik M.I. Porcine m2 muscarinic acetylcholine receptor-effector coupling in Chinese hamster ovary cells. J Biol Chem. 270:1995;15485-15493.
126. Wess J. G-protein-coupled receptors. molecular mechanisms involved in receptor activation and selectivity of G-protein recognition FASEB J. 11:1997;346-354.
127. Whaley B.S., Yuan N., Birnbaumer L., Clark R.B., Barber R. Differential expression of the β-adrenergic receptor modifies agonist stimulation of adenylyl cyclase. a quantitative evaluation Mol Pharmacol. 45:1994;481-489.
128. Williams M. Purine receptors in mammalian tissues. pharmacology and functional significance Annu Rev Pharmacol Toxicol. 27:1987;315-345.
129. s in response to muscarinic agonists. J Biol Chem. 265:1990;6219-6224.
130. Zhou Q.-Y., Li C., Olah M.E., Johnson R.A., Stiles G.L., Civelli O. Molecular cloning and characterization of a novel adenosine receptor. the A3 adenosine receptor Proc Natl Acad Sci USA. 89:1992;7432-7436.
131. 2 receptor through a protein kinase C signaling pathway Circ Res. 78:1996;73-81.
132. s-coupled receptors and dependent on receptor density. Mol Pharmacol. 46:1994;460-469.